Articles
& Blogs

In the intricate world of cell-based research and bioprocessing, precision and accuracy are paramount.

In the dynamic realm of cell-based research, reproducibility stands as the hallmark of robust scientific investigation. Yet, while the field continues to progress at a rapid clip, its practitioners often find themselves wrestling with reproducibility challenges.

Given the gravity of maintaining correctly passaged cells in culture, it's crucial to arm ourselves with strategies to prevent and, if need be, diagnose the issue.

Cell and gene therapies (CGTs) have emerged as revolutionary treatments for a wide range of diseases.

The intersection of information technology and biotechnology has never been more crucial than it is today. As the biotech industry strives to harness the power of data to accelerate research and development, events like Bio-IT World become pivotal.

In the rapidly evolving landscape of biopharmaceutical development, staying ahead of technological advancements and industry trends is not just beneficial—it's essential. CellPort is excited to attend the Bioprocessing International (BPI) West conference, March 11th through the 14th, in San Diego, where the bioprocessing community will converge.

As the bioprocessing industry continues to grow and evolve, staying at the forefront of technological advancements and innovative methods is more important than ever. CellPort is excited to attend the upcoming Bioprocessing Summit Europe, March 19th through the 21st, in Barcelona.

Cell culture labs today are struggling to handle intricate data streams produced from increasingly complex experimentation. The result: lab results that cannot be reproduced successfully.

When scaling from research to manufacturing, or passing down academic research from one group to another, enormous amounts of insights and findings must be shared without any data leakage– since even the smallest oversight could lead to a detrimental loss of science.